Does FRUQUINTINIB Cause Product dose omission issue? 94 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Product dose omission issue have been filed in association with FRUQUINTINIB (Fruzaqla). This represents 3.7% of all adverse event reports for FRUQUINTINIB.
94
Reports of Product dose omission issue with FRUQUINTINIB
3.7%
of all FRUQUINTINIB reports
23
Deaths
33
Hospitalizations
How Dangerous Is Product dose omission issue From FRUQUINTINIB?
Of the 94 reports, 23 (24.5%) resulted in death, 33 (35.1%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FRUQUINTINIB. However, 94 reports have been filed with the FAERS database.
What Other Side Effects Does FRUQUINTINIB Cause?
Death (647)
Fatigue (366)
Colon cancer (277)
Blood pressure increased (223)
Diarrhoea (213)
Colorectal cancer metastatic (212)
Decreased appetite (184)
Asthenia (178)
Dysphonia (176)
Off label use (133)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which FRUQUINTINIB Alternatives Have Lower Product dose omission issue Risk?
FRUQUINTINIB vs FULVESTRANT
FRUQUINTINIB vs FURAZOLIDONE
FRUQUINTINIB vs FUROSEMIDE
FRUQUINTINIB vs FUROSEMIDE\SPIRONOLACTONE
FRUQUINTINIB vs FUSIDATE